Hedge Fund - Broadwood Capital

The recent stock market pullback has definitely pushed companies’ valuations into cheap territory, so hedge funds and other money managers have been busy amassing “cheap” equities. In the following...

Neal C. Bradsher's Broadwood Capital revealed in a recent Form 4 filing with the SEC that it has purchased an additional 2.43 million shares of BioTime, Inc. (NYSEMKT:BTX) in a registered direct offering...

Jeremy Green, the manager of Redmile Group, is still bullish on Array Biopharma Inc (NASDAQ:ARRY) having further increased his holding of the stock. As reported in a recent Form 4 filing with the Securities...

Neal C. Bradsher’s BroadWood Capital disclosed yesterday the acquisition of 260,341 shares of STAAR Surgical Company (NASDAQ:STAA)’s Common Stock, for an average weighted price of approximately $9...

As a new filing with the Securities and Exchange revealed, Neal C. Bradsher's Broadwood Capital has acquired a significant position in BioTime, Inc. (NYSEMKT:BTX) and raised its stake to nearly 17.90...

Neal C. Bradsher, the manager of Broadwood Capital, is still bullish on BioTime, Inc. (NYSEMKT:BTX) and has further increased his fund's stake in the company. According to a recent Form 4 filing with...

In its filing with the Securities and Exchange Commission, Neal C. Bradsher's Broadwood Capital has disclosed further reducing its stake in Questcor Pharmaceuticals Inc (NASDAQ:QCOR). The filing showed...

Between Tuesday and Thursday – inclusive- Edward Lampert (ESL Investments and others) sold 1.189 million shares of AutoNation, Inc. (NYSE:AN) for prices ranging from $51.00 per share to $52.02 per share...

Neal C. Bradsher’s Broadwood Capital dumped some shares of its holding in Questcor Pharmaceuticals Inc (NASDAQ:QCOR), a newly amended filing with the SEC showed. Bradsher now holds 2.99 million shares...

Neal C. Bradsher's Broadwood Capital has trimmed its stake in Questcor Pharmaceuticals Inc (NASDAQ:QCOR) by selling 20,000 shares. According to the filing with the SEC, Broadwood disposed the securities...

Broadwood Capital, a fund managed by Neal C. Bradsher has increased its stake in BioTime, Inc. (NYSEMKT:BTX). According to a filing with the SEC, Broadwood currently holds around 9.52 million shares...